PA8464601A1 - Combinaciones de estatina-eter carboxialquilico - Google Patents
Combinaciones de estatina-eter carboxialquilicoInfo
- Publication number
- PA8464601A1 PA8464601A1 PA19988464601A PA8464601A PA8464601A1 PA 8464601 A1 PA8464601 A1 PA 8464601A1 PA 19988464601 A PA19988464601 A PA 19988464601A PA 8464601 A PA8464601 A PA 8464601A PA 8464601 A1 PA8464601 A1 PA 8464601A1
- Authority
- PA
- Panama
- Prior art keywords
- statin
- combinations
- carboxyalkyl ether
- ether
- carboxyalkyl
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Emergency Medicine (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
Abstract
LA INVENCION ES UNA COMBINACION FARMACEUTICA QUE COMPRENDE UN ETER CARBOXIALQUILICO QUE REDUCE LOS TRIGLICERIDOS Y HDL ELEVADO Y UNA ESTATINA QUE INHIBE LA REDUCTASA HMG-COA, REDUCIENDO ASI LDL, DICHA COMPOSICION ES UTIL PARA EL TRATAMIENTO DE ENFERMEDADES VASCULARES.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US6937597P | 1997-12-12 | 1997-12-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
PA8464601A1 true PA8464601A1 (es) | 2001-12-14 |
Family
ID=22088573
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PA19988464601A PA8464601A1 (es) | 1997-12-12 | 1998-12-11 | Combinaciones de estatina-eter carboxialquilico |
Country Status (30)
Country | Link |
---|---|
EP (1) | EP1045691B1 (es) |
JP (1) | JP2002508320A (es) |
KR (1) | KR20010033003A (es) |
AR (1) | AR017851A1 (es) |
AT (1) | ATE285762T1 (es) |
AU (1) | AU754089B2 (es) |
BR (1) | BR9813542A (es) |
CA (1) | CA2304612A1 (es) |
CO (1) | CO4970816A1 (es) |
CR (1) | CR5926A (es) |
CU (1) | CU20000140A7 (es) |
DE (1) | DE69828442T2 (es) |
DK (1) | DK1045691T3 (es) |
ES (1) | ES2230733T3 (es) |
GT (1) | GT199800196A (es) |
HN (1) | HN1998000185A (es) |
HU (1) | HUP0004547A3 (es) |
IL (1) | IL135349A0 (es) |
IS (1) | IS2150B (es) |
MY (1) | MY118381A (es) |
NO (1) | NO20002966L (es) |
NZ (1) | NZ503982A (es) |
PA (1) | PA8464601A1 (es) |
PE (1) | PE20000017A1 (es) |
PL (1) | PL341066A1 (es) |
PT (1) | PT1045691E (es) |
SV (1) | SV1998000146A (es) |
UY (1) | UY25299A1 (es) |
WO (1) | WO1999030704A1 (es) |
ZA (1) | ZA9811348B (es) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6861555B2 (en) | 2000-01-25 | 2005-03-01 | Warner-Lambert Company | Calcium dicarboxylate ethers, methods of making same, and treatment of vascular disease and diabetes therewith |
US20030105154A1 (en) | 2001-10-24 | 2003-06-05 | Bisgaier Charles Larry | Statin-carboxyalkylether combinations |
PL343851A1 (en) * | 1997-12-12 | 2001-09-10 | Warner Lambert Co | Antihyperlipidemic statin-lp(a) inhibitor combinations |
KR20010079955A (ko) * | 1998-09-30 | 2001-08-22 | 로즈 암스트롱, 크리스틴 에이. 트러트웨인 | 카테테르 기재 혈관재개통술의 예방 및 지연 방법 |
US6562864B1 (en) * | 1999-09-02 | 2003-05-13 | Drake Larson | Catechin multimers as therapeutic drug delivery agents |
IN191580B (es) * | 1999-12-17 | 2003-12-06 | Ranbaxy Lab Ltd | |
CN1395555A (zh) | 2000-01-25 | 2003-02-05 | 沃尼尔·朗伯公司 | 二羧酸醚钙、其制备方法、和用其治疗血管疾病和糖尿病的方法 |
AU2001256278A1 (en) * | 2000-04-18 | 2001-10-30 | Bayer Aktiengesellschaft | Use of cse inhibitors for treating heart failure |
PT1280522E (pt) * | 2000-04-26 | 2005-02-28 | Warner Lambert Co | Combinacao de eteres carboxialquilicos com anti-hipertensores e a utilizacao farmaceutica |
US6689807B1 (en) * | 2000-06-08 | 2004-02-10 | Caritas St. Elizabeth's Medical Center Of Boston, Inc. | HMG CoA reductase inhibitors for promoting angiogenesis |
US6777552B2 (en) | 2001-08-16 | 2004-08-17 | Teva Pharmaceutical Industries, Ltd. | Processes for preparing calcium salt forms of statins |
SK1402004A3 (sk) * | 2001-08-16 | 2005-01-03 | Teva Pharmaceutical Industries Ltd. | Spôsob prípravy vápenatých solí statinov |
US20050026979A1 (en) * | 2003-07-31 | 2005-02-03 | Maha Ghazzi | Methods for treating inflammation and inflammation-associated diseases with a statin and ether |
EP2800564B1 (en) | 2012-01-06 | 2020-05-06 | NeuroBo Pharmaceuticals, Inc. | Compound for use in methods of reducing risk of cardiovascular disease |
EP3370713A4 (en) * | 2015-11-06 | 2019-10-23 | Gemphire Therapeutics Inc. | TREATMENT OF MIXED DYSLIPIDEMIA |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5648387A (en) * | 1995-03-24 | 1997-07-15 | Warner-Lambert Company | Carboxyalkylethers, formulations, and treatment of vascular diseases |
-
1998
- 1998-11-12 NZ NZ503982A patent/NZ503982A/en unknown
- 1998-11-20 KR KR1020007006355A patent/KR20010033003A/ko not_active Application Discontinuation
- 1998-11-20 AU AU15915/99A patent/AU754089B2/en not_active Ceased
- 1998-11-20 PL PL98341066A patent/PL341066A1/xx unknown
- 1998-11-20 ES ES98960278T patent/ES2230733T3/es not_active Expired - Lifetime
- 1998-11-20 IL IL13534998A patent/IL135349A0/xx unknown
- 1998-11-20 PT PT98960278T patent/PT1045691E/pt unknown
- 1998-11-20 DK DK98960278T patent/DK1045691T3/da active
- 1998-11-20 EP EP98960278A patent/EP1045691B1/en not_active Expired - Lifetime
- 1998-11-20 AT AT98960278T patent/ATE285762T1/de not_active IP Right Cessation
- 1998-11-20 BR BR9813542-2A patent/BR9813542A/pt not_active Application Discontinuation
- 1998-11-20 HU HU0004547A patent/HUP0004547A3/hu unknown
- 1998-11-20 CA CA002304612A patent/CA2304612A1/en not_active Abandoned
- 1998-11-20 WO PCT/US1998/024679 patent/WO1999030704A1/en not_active Application Discontinuation
- 1998-11-20 DE DE69828442T patent/DE69828442T2/de not_active Expired - Lifetime
- 1998-11-20 JP JP2000538687A patent/JP2002508320A/ja active Pending
- 1998-12-09 HN HN1998000185A patent/HN1998000185A/es unknown
- 1998-12-10 MY MYPI98005579A patent/MY118381A/en unknown
- 1998-12-10 ZA ZA9811348A patent/ZA9811348B/xx unknown
- 1998-12-10 CR CR5926A patent/CR5926A/es not_active Application Discontinuation
- 1998-12-11 PA PA19988464601A patent/PA8464601A1/es unknown
- 1998-12-11 AR ARP980106321A patent/AR017851A1/es unknown
- 1998-12-11 SV SV1998000146A patent/SV1998000146A/es not_active Application Discontinuation
- 1998-12-11 CO CO98073828A patent/CO4970816A1/es unknown
- 1998-12-11 UY UY25299A patent/UY25299A1/es not_active Application Discontinuation
- 1998-12-11 PE PE1998001207A patent/PE20000017A1/es not_active Application Discontinuation
- 1998-12-11 GT GT199800196A patent/GT199800196A/es unknown
-
2000
- 2000-04-14 IS IS5445A patent/IS2150B/is unknown
- 2000-06-09 NO NO20002966A patent/NO20002966L/no not_active Application Discontinuation
- 2000-06-09 CU CU20000140A patent/CU20000140A7/es unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PA8464601A1 (es) | Combinaciones de estatina-eter carboxialquilico | |
AR018777A1 (es) | Composicion farmaceutica que contiene una combinacion de una estatina y aspirina y metodo. | |
DE69827821D1 (de) | Synergistisch,analgetische zusammensetzung mit opiod-analgetika und zyklooxygenase-2 inhibitoren | |
ES2178298T3 (es) | Compuestos anti-inflamatorios. | |
DE69827777D1 (de) | Zusammensetzungen mit verzögerter Wirkstoffabgabe zur Behandlung der Hyperlipidämie | |
ES2161548T3 (es) | Combinacion de un inhibidor de la aldosa reductasa y un inhibidor de la glucogeno fosforilasa. | |
GT199700009A (es) | Terapia combinada para la osteoporosis. | |
UY25714A1 (es) | Método para tratar ateroesclerosis empleando un inhibidor de ap2 y combinación. | |
ES2172793T3 (es) | Formas de dosificacion biconvexas de desintegracion rapida. | |
AR015487A1 (es) | Uso de un compuesto de colesterol hidroxilado como agente reductor para preparar una composicion farmaceutica de utilidad en un metodo para inhibirla oxidacion de las lipoproteinas en un mamifero. | |
CL2004000026A1 (es) | Uso de una composicion que comprende 0 a alrededor de 29% de cis-clomifeno y de alrededor de 100 a alrededor de 71% de trans-clomifeno para preparar un medicamento util para aumentar los niveles de testosterona en suero en un mamifero masculino. | |
CR9521A (es) | Metodo novedoso de tratamiento de la hiperlipedemia | |
BR0213181A (pt) | Combinações de inibidor de cox-2 | |
ECSP982777A (es) | Combinaciones de estatina- - eter carboxialquilico. | |
ES2189072T3 (es) | Nuevo benzo-cicloalquenos heterociclicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
EP1254667A4 (en) | MEDICINE COMPRISING A COMBINATION | |
BR9813539A (pt) | Combinações de inibidor de lp(a) e estatina anti-hiperlipidêmicas | |
DOP2001000150A (es) | Agente hipertensivo y su uso | |
PA8469001A1 (es) | Combinaciones de estatina-inhibidor de mmp. | |
AU1653100A (en) | Use of diminazene-di-aceturate for treating malaria | |
ES2166590T3 (es) | Procedimiento y compuestos intermedios para la preparacion de compuestos fluoroolefinicos plaguicidas. | |
ECSP992885A (es) | Combinaciones de estatina-inhibidor de mmp | |
ECSP003541A (es) | COMBINACION DE INHIBIDORES DE MTP E INHIBIDORES DE HMG CoA REDUCTASA Y SU USO EN MEDICAMENTOS | |
AR043506A1 (es) | Preparados de combinacion de acido acetilsalicico para la prevencion primaria de trastornos cardiovasculares | |
UY24666A1 (es) | Derivado analgesico/antiinflamatorio no ulcerogenico de clonixina |